Structurally-optimised HPV16 E7/E6 mRNA-LPP mediates dose-sparing efficacy via tumour microenvironment reprogramming. - Sun S; Deng Y; Ren J; Han X; Bing J; Wang T; Hao Z; Tian H; Zhang L; Tan W (Molecular biomedicine, 2026)